293 results
Page 4 of 15
8-K
EX-99.1
51o1tdywxl1
11 Feb 21
Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing Schedule
10:39am
8-K
EX-99.1
0ts zjtzr
26 Jan 21
Other Events
11:19am
8-K
EX-99.1
0v2ogmhj
15 Jan 21
Other Events
11:34am
8-K
h9d0x3
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
EX-10.1
iiqd0h5znxc
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
EX-99.1
xfjlhz4uckqs z6rg
7 Dec 20
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
1:22pm
8-K
EX-99.1
aa4t3bh
5 Nov 20
Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
4:09pm
8-K
EX-99.1
5hj2v0ft60osymt1
20 Oct 20
Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance
11:59am
8-K
EX-1.1
yojlxjozs7jf2xrupbe7
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-99.1
d8mtw6l8uyqt0373k
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-99.2
9pwxjj0h653zibglyi51
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-99.1
nh2o wwr3
17 Sep 20
Other Events
11:18am
8-K
EX-99.1
rmn7x6
15 Sep 20
Cardiff Oncology to Host Key Opinion Leader Call Discussing KRAS-Mutated Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial
10:36am
8-K
EX-99
jq4j7jey2189o
14 Sep 20
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
11:55am
8-K
EX-99.1
85bzhf4z4fkuwzp33
11 Aug 20
Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
4:04pm
8-K
EX-99.1
nm3y025jk5t250ry
16 Jun 20
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
4:26pm
8-K
EX-10.1
vnioxetd grggitkbw
16 Jun 20
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
4:26pm
8-K
EX-99.1
jmxuqa7zht xq
15 Jun 20
Other Events
11:50am
8-K
EX-99.1
jomsb
9 Jun 20
Other Events
11:26am